The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 aims to expand federal efforts to address PMDD, a severe menstrual health condition affecting an estimated 5 to 8 percent of women and people assigned female at birth. The bill directs the Department of Health and Human Services to increase research on PMDD's causes and treatments, launch a public awareness campaign to reduce stigma, and develop medical education materials to help healthcare providers better diagnose and treat the condition. It also establishes a grant program to train health professionals through medical schools, nursing schools, and hospitals in PMDD care. The legislation authorizes unspecified funding for these initiatives from 2026 through 2031 and requires the Secretary of Health and Human Services to report to Congress within two years on progress made in research, awareness, and treatment access.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.